相关实验视频
Updated: Feb 14, 2026
08:50
Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
16.8K
纤维细胞生长因子-23和慢性病患者的心血管疾病
Aaron Kim1, Manish A Parikh1,2, Hirra Khalid1
1From the Department of Medicine, NewYork-Presbyterian Brooklyn Methodist Hospital, Brooklyn, NY.
Cardiology in review
|February 13, 2026
概括
纤维细胞生长因子-23 (FGF-23) 在慢性病 (CKD) 中的升高将功能障碍与心脏问题联系起来. 了解FGF-23的情况
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 心脏病学 心脏病学
- 内分泌学 在内分泌学.
背景情况:
- 慢性病 (CKD) 显著增加了心血管疾病和死亡风险,超出了传统因素.
- 纤维细胞生长因子-23 (FGF-23),一种来自骨的激素,在CKD的早期上升,并调解心-骨内分泌功能障碍.
- 在CKD中病态的FGF-23信号传递通过Klotho独立通路促进心脏缩,纤维化和功能障碍.
研究的目的:
- 审查FGF-23的生理学及其在CKD相关心脏病中的病理作用.
- 检查支持FGF-23作为心血管风险生物标志物的临床证据.
- 讨论针对FGF-23-Klotho-FGFR轴的当前和新兴治疗策略.
主要方法:
- 对FGF-23,CKD和心血管结果的现有文献的审查.
- 对表现出FGF-23对心脏事件的预测价值的队列研究的分析.
- 对FGF-23的心脏信号通路的机械学研究的审查.
主要成果:
- 升高的FGF-23可以独立预测CKD和非CKD群体的左心室缩,心力衰竭,心房动和死亡率.
- FGF-23 作为心血管风险的生物标志物,特别是在心力衰竭中具有保存的喷射分数.
- 临床使用受到测试变异性和缺乏结果证明干预措施的限制.
结论:
- FGF-23是一个关键的调解者,将CKD与心血管并发症联系起来.
- 准FGF-23-Klotho-FGFR轴代表了潜在的治疗策略,用于心脏脏保护.
- 需要进一步的研究来规范FGF-23评估和验证治疗干预措施.
相关概念视频
01:25Chronic Kidney Disease I: Introduction
768
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
768
01:24Chronic Kidney Disease II: Clinical Manifestations
688
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
688
01:28Chronic Kidney Disease III: Interprofessional Care
485
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
485
01:18Chronic Kidney Disease IV: Nursing Management
416
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
416
01:27Psychoneuroimmunology: Cardiovascular Disease
584
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
A key area of focus in PNI is the relationship between stress and coronary...
584
01:24Chronic Obstructive Pulmonary Disease
2.6K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.6K